Fulminant encephalopathy with basal ganglia hyperintensities in HIV-infected drug users

Neurology

Volumn 76, Issue 9, 2011, Pages 787-794

  Newsome, S D ^a   Johnson, E ^a   Pardo, C ^a   McArthur, J C ^a   Nath, A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COCAINE; DIAMORPHINE;

ADULT; ARTICLE; AUTOPSY; BASAL GANGLION; BRAIN DISEASE; CELL ACTIVATION; CLINICAL ARTICLE; COCAINE DEPENDENCE; DISEASE ASSOCIATION; DRUG ABUSE; FEMALE; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; KIDNEY FAILURE; MALE; MENTAL DEFICIENCY; MICROGLIA; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; SURVIVAL RATE; VIRUS LOAD;

ADULT; AIDS DEMENTIA COMPLEX; BASAL GANGLIA; DRUG USERS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS; SYNDROME;

EID: 79952405726     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31820e7b4e     Document Type: Article

References (40)

1. Hicks PL, Mulvey KP, Chander G, et al. The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care 2007;19:1134-1140. (Pubitemid 350223192)
2. Cook JA, Burke-Miller JK, Cohen MH, et al. Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS 2008;22:1355-1363.
3. Arnsten JH, Demas PA, Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 2002;17:377-381. (Pubitemid 34626108)
4. Berger JR, Arendt G. HIV dementia: the role of the basal ganglia and dopaminergic systems. J Psychopharmacol 2000;14:214-221.
5. Avison MJ, Nath A, Greene-Avison R, Schmitt FA, Greenberg RN, Berger JR. Neuroimaging correlates of HIV-associated BBB compromise. J Neuroimmunol 2004; 157:140-146. (Pubitemid 39576648)
6. Nath A, Hauser KF, Wojna V, et al. Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 2002;31(suppl 2):S62-S69. (Pubitemid 35190560)
7. Gillams AR, Allen E, Hrieb K, Venna N, Craven D, Carter AP. Cerebral infarction in patients with AIDS. AJNR Am J Neuroradiol 1997;18:1581-1585. (Pubitemid 30413977)
8. Meltzer CC, Wells SW, Becher MW, Flanigan KM, Oyler GA, Lee RR. AIDS-related MR hyperintensity of the basal ganglia. AJNR Am J Neuroradiol 1998;19:83-89. (Pubitemid 30430588)
9. Kenedi CA, Joynt KE, Goforth HW. Comorbid HIV encephalopathy and cocaine use as a risk factor for new-onset seizure disorders. CNS Spectr 2008;13:230-234.
10. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005;57:67-81. (Pubitemid 40053317)
11. Turchan J, Anderson C, Hauser KF, et al. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci 2001;2:3.
12. Kure K, Lyman WD, Weidenheim KM, Dickson DW. Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. Am J Pathol 1990;136: 1085-1092. (Pubitemid 20188495)
13. Banks WA, Robinson SM, Nath A. Permeability of the blood-brain barrier to HIV-1 Tat. Exp Neurol 2005;193: 218-227. (Pubitemid 40463283)
14. Bruce-Keller AJ, Chauhan A, Dimayuga FO, Gee J, Keller JN, Nath A. Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain. J Neurosci 2003;23:8417-8422. (Pubitemid 37129659)
15. Bell JE, Brettle RP, Chiswick A, Simmonds P. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS: effect of neocortical involvement. Brain 1998;121:2043-2052. (Pubitemid 28497903)
16. Royal W 3rd, Updike M, Selnes OA, et al. HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology 1991;41:1905-1910.
17. Nath A, Maragos W, Avison M, Schmitt F, Berger J. Accelerated HIV dementia with methamphetamine and cocaine use. J Neurovirol 2001;7:66-71. (Pubitemid 32904361)
18. Gurwell JA, Nath A, Sun Q, et al. Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience 2001; 102:555-563. (Pubitemid 32171876)
19. Koob GF. Neurobiology of addiction: toward the development of new therapies. Ann NY Acad Sci 2000;909:170-185. (Pubitemid 30462039)
20. Hu S, Sheng WS, Lokensgard JR, Peterson PK. Morphine potentiates HIV-1 gp120-induced neuronal apoptosis. J Infect Dis 2005;191:886-889. (Pubitemid 40349803)
21. Bruce-Keller AJ, Turchan-Cholewo J, Smart EJ, et al. Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice. Glia 2008;56:1414-1427.
22. Wilson JM, Levey AI, Bergeron C, et al. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann Neurol 1996;40: 428-439. (Pubitemid 26304800)
23. Weiner WJ, Rabinstein A, Levin B, Weiner C, Shulman LM. Cocaine-induced persistent dyskinesias. Neurology 2001;56:964-965. (Pubitemid 32290816)
24. Andras IE, Pu H, Deli MA, Nath A, Hennig B, Toborek M. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J Neurosci Res 2003;74:255-265. (Pubitemid 37193712)
25. Berger JR, Avison M. The blood brain barrier in HIV infection. Front Biosci 2004;9:2680-2685.
26. Petito CK, Cash KS. Blood-brain barrier abnormalities in AIDS: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 1992;32:658-666.
27. Fiala M, Eshleman AJ, Cashman J, et al. Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells. J Neurovirol 2005;11:281-291. (Pubitemid 41122416)
28. Kumar R, Torres C, Yamamura Y, et al. Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus. J Virol 2004;78:11425-11428. (Pubitemid 39299687)
29. Rogers TJ, Peterson PK. Opioid G protein-coupled receptors: signals at the crossroads of inflammation. Trends Immunol 2003;24:116-121. (Pubitemid 36263094)
30. Li Y, Wang X, Tian S, Guo CJ, Douglas SD, Ho WZ. Methadone enhances human immunodeficiency virus infection of human immune cells. J Infect Dis 2002;185: 118-122. (Pubitemid 34043026)
31. Noel RJ Jr, Kumar A. Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques. Virology 2006;346:127-138. (Pubitemid 43254705)
32. Roth MD, Tashkin DP, Choi R, Jamieson BD, Zack JA, Baldwin GC. Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. J Infect Dis 2002;185:701-705. (Pubitemid 34171478)
33. Dhillon NK, Williams R, Peng F, et al. Cocaine-mediated enhancement of virus replication in macrophages: implica-tions for human immunodeficiency virus-associated dementia. J Neurovirol 2007;13:483-495.
34. Reynolds JL, Mahajan SD, Bindukumar B, Sykes D, Schwartz SA, Nair MP. Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res 2006;1123:226-236.
35. Nair MP, Mahajan SD, Schwartz SA, et al. Cocaine modulates dendritic cell-specific C type intercellular adhesion molecule-3-grabbing nonintegrin expression by dendritic cells in HIV-1 patients. J Immunol 2005;174:6617-6626. (Pubitemid 40705622)
36. Wyatt CM, Rosenstiel PE, Klotman PE. HIV-associated nephropathy. Contrib Nephrol 2008;159:151-161.
37. Gitman MD, Singhal PC. Cocaine-induced renal disease. Expert Opin Drug Saf 2004;3:441-448. (Pubitemid 39242718)
38. Li JY, Yong TY, Sebben R, Khoo E, Disney AP. Bilateral basal ganglia lesions in patients with end-stage diabetic nephropathy. Nephrology 2008;13:68-72.
39. Letendre SL, Cherner M, Ellis RJ, et al. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. Aids 2005;19(suppl 3):S72-S78. (Pubitemid 41682172)
40. Clifford DB, Smurzynski M, Park LS, et al. Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients. Neurology 2009;73: 309-314.